Enasidenib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Enasidenib is used to treat acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation in patients who have not responded to other treatments or to those whose cancer has come back after treatment.Enasidenib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Enasidenib Nitroso Impurity 2 CAS NO: NA chemically represented as N-(4-((2-Hydroxy-2-methylpropyl)(nitroso)amino)-6-(6-(trifluoromethyl)pyridin-2-yl)-1,3,5-triazin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)nitrous amide. Synchemia is the leading manufacturing and exporter of Enasidenib Nitroso Impurity 2 . We supply Enasidenib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142051 |
| CAS No | NA |
| Mol.F. | C6H6N6O3 |
| Mol.Wt. | 210.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142052 |
| CAS No | NA |
| Mol.F. | C12H16N6O7 |
| Mol.Wt. | 356.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142053 |
| CAS No | NA |
| Mol.F. | C6H8N6O3 |
| Mol.Wt. | 212.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142054 |
| CAS No | NA |
| Mol.F. | C7H7BrN2O |
| Mol.Wt. | 215.05 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142055 |
| CAS No | NA |
| Mol.F. | C7H8N2O2 |
| Mol.Wt. | 152.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142056 |
| CAS No | NA |
| Mol.F. | C13H13N3O2 |
| Mol.Wt. | 243.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142057 |
| CAS No | NA |
| Mol.F. | C15H17N3O2 |
| Mol.Wt. | 271.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142058 |
| CAS No | NA |
| Mol.F. | C20H29N3O6 |
| Mol.Wt. | 407.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142059 |
| CAS No | NA |
| Mol.F. | C19H27N3O6 |
| Mol.Wt. | 393.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142060 |
| CAS No | 3050754-68-9 |
| Mol.F. | C29H26ClN7O4 |
| Mol.Wt. | 572 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142061 |
| CAS No | NA |
| Mol.F. | C13H12ClN3O2 |
| Mol.Wt. | 277.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142062 |
| CAS No | NA |
| Mol.F. | C24H19CLN6O3 |
| Mol.Wt. | 474.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142063 |
| CAS No | NA |
| Mol.F. | C30H28CLN7O5 |
| Mol.Wt. | 602 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142064 |
| CAS No | NA |
| Mol.F. | C30H28CLN7O6 |
| Mol.Wt. | 618 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142065 |
| CAS No | NA |
| Mol.F. | C15H13N5O2 |
| Mol.Wt. | 295.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142066 |
| CAS No | NA |
| Mol.F. | C15H14ClN5O2 |
| Mol.Wt. | 331.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |